Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5438
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data ; volume:28 ; number:12 ; day:9 ; month:7 ; year:2020 ; pages:1662-1668 ; date:12.2020
European journal of human genetics ; 28, Heft 12 (9.7.2020), 1662-1668, 12.2020
- Creator
-
Riccio, Eleonora
Zanfardino, Mario
Ferreri, Lucia
Santoro, Ciro
Cocozza, Sirio
Capuano, Ivana
Imbriaco, Massimo
Feriozzi, Sandro
Pisani, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41431-020-0677-x
- URN
-
urn:nbn:de:101:1-2021011019011849034866
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Riccio, Eleonora
- Zanfardino, Mario
- Ferreri, Lucia
- Santoro, Ciro
- Cocozza, Sirio
- Capuano, Ivana
- Imbriaco, Massimo
- Feriozzi, Sandro
- Pisani, Antonio
- SpringerLink (Online service)
Other Objects (12)
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Hermann
Fabry, Ilana
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Hermann
Fabry, Ilana
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
Histone chaperone exploits intrinsic disorder to switch acetylation specificity
A switch point in the molecular chaperone Hsp90 responding to client interaction
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease
Molekulare Chaperone
Co-chaperone interactions in the Hsp90 chaperone cycle
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy
Response to “Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data”
How to switch a master switch
Fabry, Hermann